Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 30 of the 36 references it cites were found in a registry or an index; none of the 10 sources its claims cite is checked for support yet.

A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obsessive–compulsive disorder

Open access
Ebrahimi, Amrollah, Nasre Esfahan, Elham, Akuchekian, Shahla, Izadi, Razieh, Shaneh, Elham, Mahaki, Behzad · 2022 · Journal of Research in Medical Sciences

Abstract

Background: Acceptance and commitment therapy (ACT) is one of the newest treatment strategies that has been developed rapidly to improve the treatment of patients with obsessive–compulsive disorder (OCD). The aim of this study was to evaluate and compare the effect of ACT and selective serotonin reuptake inhibitors (SSRIs) drugs on the severity of depression symptoms and quality of life (QOL) in obsessive–compulsive patients. Materials and Methods: A randomized clinical trial with a control group was conducted including 27 patients with OCD. Based on the Diagnostic and Statistical Manual of Mental Disorders‑5 criteria for OCD diagnosis, participants were recruited from Tamasha Counseling Center and obsessive–compulsive clinic in the Psychosomatic Research Center in Isfahan, Iran. Selected patients were allocated to two groups (14 in ACT the group and 13 in the drug group with SSRI with a simple random sampling method. ACT group was treated by an ACT therapist in eight 1‑h sessions. Data were collected by the World Health Organization QOL Questionnaire (WHOQOL‑BREF) and Depression subscale of DASS‑42 at admission, after the intervention, and 3 months thereafter. Therapists and evaluators were blind to each other’s work. Data were analyzed using analysis of variance with repeated measures method using IBM SPSS Statistics software (V 23, IBM Corporation, Armonk, NY, USA). Results: Results revealed that both treatments (ACT and SSRIs drug therapy) had significant impacts on reducing depression subscales scores and increasing WHOQOL‑BREF scores at posttreatment (P < 0.05). There were no significant differences in QOL scores between the two groups after the intervention and follow‑up (P > 0.05). Nevertheless, drug therapy presented a significantly greater improvement in depression scores of patients than those resulting from ACT (P = 0.005). The persistence of treatment effects continued after 3 months (follow‑up) in both groups. Conclusion: ACT is equal to SSRIs drug therapy in terms of improving QOL in patients with OCD. However, SSRIs are more effective in treating depression in obsessive–compulsive patients. It may be presumed that ACT without any chemical side effect is equal to drug and is preferred for patients who either cannot use drugs or prefer not to have a drug treatment. © 2022 Journal of Research in Medical Sciences | Published by Wolters Kluwer - Medknow.

Overview

CoChat Summary

## TL;DR

This randomized clinical trial compared group acceptance and commitment therapy (ACT) with SSRI drug treatment for 27–30 patients with obsessive–compulsive disorder (OCD), focusing on quality of life (QOL) and depression. Both treatments improved QOL and reduced depression, but SSRIs produced a greater improvement in depression, while ACT was comparable to SSRIs for QOL.

## Key findings

  • In the abstract, both ACT and SSRI therapy had significant effects on reducing depression scores and increasing WHOQOL-BREF scores at posttreatment (`P < 0.05`).
  • There were no significant differences in QOL between the two groups after the intervention and at follow-up (`P > 0.05`), and effects persisted after 3 months in both groups.
  • Drug therapy showed a significantly greater improvement in depression scores than ACT (`P = 0.005` in the abstract; `P < 0.05` in the results text).
  • Group characteristics were similar at baseline: ACT group mean age `32.71 ± 8.27` years and drug group `31 ± 7.43` years; age, sex, marital status, and education status were not significantly different between groups.

## Methods

  • Randomized controlled trial with a control group, comparing eight 1-hour ACT sessions over 1 month versus routine SSRI treatment.
  • Participants were OCD patients recruited from Tamasha Counseling Center and an obsessive–compulsive clinic in Isfahan, Iran; eligibility was based on DSM-5 criteria, age 18–65, and absence of specified severe comorbidities.
  • Outcomes were measured at admission, after treatment, and 3 months later using WHOQOL-BREF and the DASS-42 depression subscale; repeated-measures ANOVA was used for analysis, adjusting for pretest scores and age.

## Limitations

  • The paper states that generalization should be cautious because patients came from university-affiliated medical centers and sessions were intensive, so results may not apply to patients from private centers.
  • The paper states that outcomes relied on self-report questionnaires, so other assessment methods are needed to determine clinically significant effectiveness.
  • Evident from the text: the analyzed sample was small, with 13 ACT and 14 drug participants completing the study, which limits precision and broader inference.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.4103/jrms.jrms_449_21

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 CONSORT diagram for a clinical trial of acceptance and commitment therapy and selective serotonin reuptake inhibitor treatment among patients with obsessive–compulsive disorder
Figure 1 CONSORT diagram for a clinical trial of acceptance and commitment therapy and selective serotonin reuptake inhibitor treatment among patients with obsessive–compulsive disorderCC BY-NC-SA · PubMed Central
Figure 2 Changes in World Health Organization Quality of Life Questionnaire-Brief scores before, after, and over 3 months of follow-up in two groups
Figure 2 Changes in World Health Organization Quality of Life Questionnaire-Brief scores before, after, and over 3 months of follow-up in two groupsCC BY-NC-SA · PubMed Central
Figure 3 Changes in depression scores before, after, and over 3 months of follow-up in two groups
Figure 3 Changes in depression scores before, after, and over 3 months of follow-up in two groupsCC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 10 Not checked · 21 Own results and interpretations

6 more claims

Create a free account to see all 31 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 17
  • Probably not a substantial claim. 9

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 36 references

Research works printed but not linked: 2

  1. Anvari, 2014, The effectiveness of group-based acceptance and commitment therapy on pain-related anxiety, acceptance of pain and pain intensity in patients with chronic pain, J Isfahan Med Sch, 32, 1156
  2. Nejat, 2006, The World Health Organization Quality of Life questionnaire: Translation and validation study of the Iranian Version, J Sch Public Health Inst Public Health Res, 4, 1

Cited by

See all 9

Metadata

Authors
Ebrahimi, A., Nasre Esfahan, E., Akuchekian, S., Izadi, R., Shaneh, E., & Mahaki, B.
Affiliations
  • Isfahan University of Medical Sciences (IR)
  • University of Isfahan (IR)
  • Kermanshah University of Medical Sciences (IR)
Corresponding author
Ebrahimi, Amrollah
Venue
Journal of Research in Medical Sciences
Published
2022-01
Volume
27
Issue
1
Pages
9
ISSN
1735-1995 (ISSN-L)
OpenAlex
W4212857057
Cited by
9
References
36
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 2
FWCI
1.83
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • Journal of Research in Medical Sciences (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
acceptance and commitment therapy, obsessive-compulsive disorder, selective serotonin reuptake inhibitors, depressive symptoms, quality of life, psychotherapy versus pharmacotherapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obsessive–compulsive disorder. https://app.cochat.ai/papers/10.4103/jrms.jrms_449_21
The paper
Ebrahimi, A., Nasre Esfahan, E., Akuchekian, S., Izadi, R., Shaneh, E., & Mahaki, B. (2022). A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obsessive–compulsive disorder. Journal of Research in Medical Sciences. https://doi.org/10.4103/jrms.jrms_449_21

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.